Clarivate (CLVT)
undefined
undefined%
At close: undefined
5.30
3.72%
After-hours Dec 13, 2024, 06:49 PM EST

Company Description

Clarivate Plc, an information services and analytics company, provides structured information and analytics for discovery, protection, and commercialization of scientific research, innovations, and brands.

It offers Web of Science products and services, such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio to organizations that plan, fund, implement, and utilize research; and Life Sciences products, including Cortellis and Newport Integrity for pharmaceutical and biotechnology companies to support research, market intelligence, and competitive monitoring in connection with the development and commercialization of new drugs.

The company also provides Derwent products, which include Derwent Innovation, Techstreet, and IP Professional Services that enables its customers to evaluate the novelty of potential new products, confirm freedom to operate with respect to their product design, help them secure patent protection, assess the competitive technology landscape, and ensure that their products comply with required industry standards; CompuMark products, such as trademark screening, searching, and watching products and services for businesses and law firms; and MarkMonitor products, which helps enterprises to establish, manage, optimize, and protect their online presence.

It serves government and academic institutions, life science companies, and research and development corporations in the Americas, the Middle East, Africa, Europe, and the Asia Pacific.

The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020.

Clarivate Plc is headquartered in London, the United Kingdom.

Clarivate
Clarivate logo
Country GB
IPO Date Oct 29, 2018
Industry Information Technology Services
Sector Technology
Employees 12,000
CEO Matti Shem Tov

Contact Details

Address:
70 St. Mary Axe
London,
GB
Website https://www.clarivate.com

Stock Details

Ticker Symbol CLVT
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001764046
CUSIP Number G21810109
ISIN Number JE00BJJN4441
Employer ID 00-0000000
SIC Code 7374

Key Executives

Name Position
Matti Shem Tov Chief Executive Officer & Director
Jonathan M. Collins Executive Vice President & Chief Financial Officer
William E. Graff Executive Vice President & Chief Information Officer
Bar Veinstein President of Academia & Government
Gordon Samson President of Intellectual Property
Henry Levy President of Life Sciences & Healthcare
Mark J. Donohue CPA Head of Investor Relations
Michael Easton Senior Vice President of Finance & Chief Accounting Officer
Richard C. Finch Global Head of Life Sciences Consulting Services
Tabita Andersson Senior Vice President of Communications & Brand

Latest SEC Filings

Date Type Title
Dec 05, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Nov 22, 2024 4 Filing
Nov 19, 2024 4 Filing
Nov 13, 2024 SC 13G Statement of acquisition of beneficial ownership b...
Nov 06, 2024 10-Q Quarterly Report
Nov 06, 2024 8-K Current Report
Oct 17, 2024 4 Filing
Oct 02, 2024 4 Filing
Oct 02, 2024 4 Filing
Oct 02, 2024 4 Filing